Neural Therapeutics Inc. (CSE:NURL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
At close: Apr 25, 2025
33.33%
Market Cap 3.55M
Revenue (ttm) n/a
Net Income (ttm) -548.15K
Shares Out 88.70M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 131,970
Average Volume 85,614
Open 0.0400
Previous Close 0.0400
Day's Range 0.0350 - 0.0400
52-Week Range 0.0200 - 0.0350
Beta n/a
RSI 60.32
Earnings Date Apr 1, 2025

About Neural Therapeutics

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NURL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.